VANCOUVER, British Columbia, October 7, 2011 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued Equity Research for top traded penny stocks: Cheniere Energy (AMEX:LNG), Golden Star (AMEX:GSS), Antares Pharma (AMEX:AIS). More reports for Intel (NASDAQ:INTC), Apple (NASDAQ:AAPL) & Level 3 Communications (NASDAQ:LVLT).
Investing in penny stocks is a very risky short term investment given the high price volatility and lack of transparency to corporate management. One way to find out the quality of corporate governance in penny stocks is to track if all insiders such as CEOs, CFOs, and all Directors are following policy in trading company stocks.
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Research Report Highlights:
Cheniere Energy, Inc. (AMEX:LNG): Company CEO Sold Stock
Insider Trade Signals: Cheniere Energy, Inc., through subsidiaries, develops liquefied natural gas terminals, and explores for oil and natural gas. The Company explores for oil and gas in the Gulf of Mexico. PSI found company Chairman of the Board of Directors, President, Chief Executive Officer - Charif Souki sold his shares on October 3 at a 52-week low price. Want to find out if insiders are trading at the same time and same direction?
Read Full Report: http://www.Pennystocksinsiders.com/PR/100711A/LNG/CheniereEnergy.pdf
Golden Star Resources Ltd. (USA) (AMEX:GSS): Stock Price in 52-week Low While Gold Price Dropping
Insider Trade Signals: Golden Star Resources Ltd. (Amex: GSS) today announced that William L. Yeates, CPA, a veteran accounting industry executive with specialization in extractive industries, has joined the Company's board of directors. The addition of Mr. Yeates, 63, raises to eight the total number of Golden Star directors. Want to track these insiders' trading activities from now on?
Read Full Report: http://www.Pennystocksinsiders.com/PR/100711A/GSS/GoldenStarResources.pdf
Antares Pharma Inc (AMEX:AIS): Do Insiders Have Confidence in Biotech
Insider Trade Signals: Antares Pharma, Inc. (Antares) is a pharmaceutical company that focuses on self-injection pharmaceutical products and technologies and gel-based products. Do you want to know if any institutional investors are buying/selling the stocks you are holding?
Read Full Report: http://www.Pennystocksinsiders.com/PR/100711A/AIS/AntaresPharma.pdf
Today we released other research reports for:
Intel Corporation (NASDAQ:INTC)
Read Full Report: http://www.Pennystocksinsiders.com/PR/100711A/INTC/Intel.pdf
Apple Inc. (NASDAQ:AAPL)
Read Full Report: http://www.Pennystocksinsiders.com/PR/100711A/AAPL/Apple.pdf
Level 3 Communications, Inc. (NASDAQ:LVLT)
Read Full Report: http://www.Pennystocksinsiders.com/PR/100711A/LVLT/Level3Communications.pdf
More Individual Stock Reports & Sector Reports:
http://www.Pennystocksinsiders.com/mediaroom/
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Pennystocksinsiders.com:
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit http://www.Pennystocksinsiders.com/disclaimers/index.php for details.
